Kingfa Science & Technology (India) Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 3/6
Kingfa Science & Technology (India) verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 47.2%, während die Gewinne der Branche Chemicals jährlich um gewachsen und zwar um 15.6%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 20.9%. Die Eigenkapitalrendite von Kingfa Science & Technology (India) beträgt 20.6% und die Nettomargen betragen 8.2%.
Wichtige Informationen
47.2%
Wachstumsrate der Gewinne
47.2%
EPS-Wachstumsrate
Chemicals Wachstum der Industrie | 17.7% |
Wachstumsrate der Einnahmen | 20.9% |
Eigenkapitalrendite | 20.6% |
Netto-Marge | 8.2% |
Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Market Might Still Lack Some Conviction On Kingfa Science & Technology (India) Limited (NSE:KINGFA) Even After 43% Share Price Boost
Aug 21Investors Still Aren't Entirely Convinced By Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Earnings Despite 36% Price Jump
Jul 04Kingfa Science & Technology (India)'s (NSE:KINGFA) Solid Profits Have Weak Fundamentals
Jun 05Returns on Capital Paint A Bright Future For Kingfa Science & Technology (India) (NSE:KINGFA)
May 01Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Subdued P/E Might Signal An Opportunity
Mar 12Kingfa Science & Technology (India) (NSE:KINGFA) Is Very Good At Capital Allocation
Aug 26If EPS Growth Is Important To You, Kingfa Science & Technology (India) (NSE:KINGFA) Presents An Opportunity
Jul 29Kingfa Science & Technology (India) (NSE:KINGFA) Could Become A Multi-Bagger
May 26Kingfa Science & Technology (India) (NSE:KINGFA) Is Very Good At Capital Allocation
Feb 11We Think Kingfa Science & Technology (India) (NSE:KINGFA) Can Stay On Top Of Its Debt
Jan 01Kingfa Science & Technology (India) (NSE:KINGFA) Might Have The Makings Of A Multi-Bagger
Aug 12Does Kingfa Science & Technology (India) (NSE:KINGFA) Have A Healthy Balance Sheet?
Jun 17Kingfa Science & Technology (India)'s (NSE:KINGFA) Returns On Capital Not Reflecting Well On The Business
May 07Does Kingfa Science & Technology (India) (NSE:KINGFA) Have A Healthy Balance Sheet?
Jan 25We're Watching These Trends At Kingfa Science & Technology (India) (NSE:KINGFA)
Mar 08Is Kingfa Science & Technology (India) (NSE:KINGFA) Using Too Much Debt?
Feb 09Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 13Kingfa Science & Technology (India)'s (NSE:KINGFA) Stock Price Has Reduced 30% In The Past Three Years
Dec 23Our Take On The Returns On Capital At Kingfa Science & Technology (India) (NSE:KINGFA)
Dec 02These 4 Measures Indicate That Kingfa Science & Technology (India) (NSE:KINGFA) Is Using Debt Extensively
Nov 11Is Kingfa Science & Technology (India) Limited's (NSE:KINGFA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 13If You Had Bought Kingfa Science & Technology (India)'s (NSE:KINGFA) Shares Three Years Ago You Would Be Down 34%
Sep 17We're Watching These Trends At Kingfa Science & Technology (India) (NSE:KINGFA)
Aug 27Earnings Tell The Story For Kingfa Science & Technology (India) Limited (NSE:KINGFA)
Aug 06Kingfa Science & Technology (India) Limited (NSE:KINGFA) Not Flying Under The Radar
Jul 22Kingfa Science & Technology (India) (NSE:KINGFA) Has A Pretty Healthy Balance Sheet
Jul 01Aufschlüsselung der Einnahmen und Ausgaben
Wie Kingfa Science & Technology (India) Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Sep 24 | 16,330 | 1,342 | 395 | 0 |
30 Jun 24 | 15,655 | 1,266 | 311 | 0 |
31 Mar 24 | 14,877 | 1,225 | 349 | 0 |
31 Dec 23 | 14,508 | 1,256 | 360 | 0 |
30 Sep 23 | 13,961 | 1,215 | 343 | 0 |
30 Jun 23 | 13,965 | 1,140 | 256 | 0 |
31 Mar 23 | 14,037 | 814 | 321 | 0 |
31 Dec 22 | 13,406 | 488 | 274 | 0 |
30 Sep 22 | 12,579 | 360 | 238 | 0 |
30 Jun 22 | 11,714 | 214 | 208 | 0 |
31 Mar 22 | 10,479 | 306 | 227 | 0 |
31 Dec 21 | 9,646 | 283 | 201 | 0 |
30 Sep 21 | 9,020 | 224 | 200 | 0 |
30 Jun 21 | 8,044 | 183 | 177 | 0 |
31 Mar 21 | 6,272 | 53 | 254 | 0 |
31 Dec 20 | 5,854 | 43 | 224 | 0 |
30 Sep 20 | 5,800 | 103 | 219 | 0 |
30 Jun 20 | 6,027 | 129 | 154 | 0 |
31 Mar 20 | 7,415 | 246 | 171 | 0 |
31 Dec 19 | 7,430 | 365 | 127 | 0 |
30 Sep 19 | 7,179 | 342 | 143 | 0 |
30 Jun 19 | 7,157 | 288 | 114 | 0 |
31 Mar 19 | 7,015 | 191 | 142 | 0 |
31 Dec 18 | 6,924 | 144 | 182 | 0 |
30 Sep 18 | 6,921 | 173 | 174 | 0 |
30 Jun 18 | 6,449 | 219 | 169 | 0 |
31 Mar 18 | 6,016 | 246 | 136 | 0 |
31 Dec 17 | 5,461 | 207 | 151 | 0 |
30 Sep 17 | 4,933 | 139 | 148 | 0 |
30 Jun 17 | 4,655 | 129 | 128 | 0 |
31 Mar 17 | 4,271 | 124 | 141 | 0 |
31 Dec 16 | 4,000 | 134 | 127 | 0 |
30 Sep 16 | 3,650 | 159 | 118 | 0 |
30 Jun 16 | 3,395 | 139 | 101 | 0 |
31 Mar 16 | 3,142 | 108 | 104 | 0 |
31 Dec 15 | 2,814 | 67 | 216 | 17 |
30 Sep 15 | 2,600 | 12 | 214 | 17 |
30 Jun 15 | 2,305 | -25 | 212 | 17 |
31 Mar 15 | 2,188 | -30 | 90 | 0 |
31 Dec 14 | 2,132 | -72 | 174 | 11 |
30 Sep 14 | 2,034 | -75 | 171 | 11 |
30 Jun 14 | 1,893 | -84 | 168 | 11 |
31 Mar 14 | 1,778 | -85 | 166 | 11 |
31 Dec 13 | 1,637 | -72 | 130 | 3 |
Qualität der Erträge: KINGFA einen hohen Anteil an unbarem Gewinn hat.
Wachsende Gewinnspanne: KINGFADie aktuellen Gewinnspannen (8.2%) sind niedriger als im letzten Jahr (8.7%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: KINGFAIn den letzten 5 Jahren sind die Einnahmen von 47.2% pro Jahr erheblich gestiegen.
Beschleunigtes Wachstum: KINGFADas Gewinnwachstum des Unternehmens im letzten Jahr (10.5%) liegt unter seinem 5-Jahres-Durchschnitt (47.2% pro Jahr).
Erträge im Vergleich zur Industrie: KINGFA Das Gewinnwachstum im vergangenen Jahr (10.5%) übertraf das der Branche Chemicals 10% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: KINGFADie Eigenkapitalrendite des Unternehmens (20.6%) wird als hoch angesehen.